Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

Fiona Coats, Chief Marketing Officer, Refeyn

Oxford, UK – Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.  Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.

Educated in the UK, Fiona holds a Ph.D. in Physiology/Pharmacology and a B.Sc. in Pharmacology, and has successfully leveraged her scientific insights to excel in strategic marketing and drive business expansion. Her career highlights include spearheading revenue growth, crafting cutting-edge go-to-market strategies, and overseeing product management within the competitive life science research arena.

Fiona’s professional journey includes pivotal roles at Biosource International, Meso Scale Diagnostics, ThermoFisher Scientific and more recently at Sartorius, where she has consistently excelled in building brands and expanding market presence. She has managed global teams and budgets with a focus on transformative returns through innovative marketing strategies targeting attractive growth segments. As she takes on the role of Chief Marketing Officer, Fiona’s expertise is expected to drive the company’s growth and solidify its market position. Her dynamic and informed marketing leadership is set to propel the company towards a future of sustained success.

To find out more about Refeyn and mass photometry, please visit:

– ENDS –

Editor’s notes

About Refeyn

Refeyn Ltd. specializes in the development, production, and distribution of mass photometry technologies for industry and academia. Mass photometry and macro mass photometry are unique bioanalytical technologies pioneered by Refeyn. By quantifying light scattering from particles in solution, mass photometry enables the measurement of molecular mass at the single-particle level while macro mass photometry enables simultaneous measurement of viral vector size and contrast (a proxy for mass).

Spun out of Oxford University in 2018, the company aims to make its technology accessible to all in the scientific community, enabling users to achieve new and better outcomes. Refeyn has been recognized for its unique approach to biomolecular analysis through multiple awards, including the Royal Society of Chemistry Emerging Technologies Competition. Applications of mass photometry include: Characterization of samples of biomolecules and viral vectors, and analysis of protein oligomerization, biomolecular interactions, and macromolecular assemblies. Utilizing the novel technologies of mass photometry and macro mass photometry, Refeyn’s products are capable of accurate analysis of single particles in solution, in their native state, and without the need for labels, opening up new possibilities for bioanalytics.


< | >